EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
-5.65%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.02B
AUM Growth
+$1.02B
(-5.8%)
Cap. Flow
+$84.8M
Cap. Flow
% of AUM
8.28%
Top 10 Holdings %
Top 10 Hldgs %
54.92%
Holding
96
New
13
Increased
32
Reduced
16
Closed
24
Top Buys
| 1 |
Sanofi
SNY
|
$44M |
| 2 |
SPDR S&P Biotech ETF
XBI
|
$26.4M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$22.3M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$19.1M |
| 5 |
AstraZeneca
AZN
|
$18.2M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$49M |
| 2 |
HCA Healthcare
HCA
|
$27.9M |
| 3 |
Masimo
MASI
|
$26.5M |
| 4 |
ARK Genomic Revolution ETF
ARKG
|
$21.6M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$16.2M |
Sector Composition
| 1 | Healthcare | 95.7% |
| 2 | Industrials | 1.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Labcorp
LH
$22.7B
| $1.25M | 0.09% |
5,354
-32,556
| -86% | -$7.63M |
|
|
WHWK
52
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$88.1M
| $1.24M | 0.09% |
100,817
-50,000
| -33% | -$616K |
|
53
Icon
ICLR
$14B
| $1.21M | 0.09% |
5,587
-41,229
| -88% | -$8.93M |
|
54
DexCom
DXCM
$30.1B
| $1.08M | 0.08% |
14,468
-13,936
| -49% | -$1.04M |
|
55
Zentalis Pharmaceuticals
ZNTL
$126M
| $1.08M | 0.08% |
38,342
-61,845
| -62% | -$1.74M |
|
56
Repligen
RGEN
$6.71B
| $925K | 0.07% |
5,693
-30,828
| -84% | -$5.01M |
|
57
Milestone Pharmaceuticals
MIST
$153M
| $905K | 0.06% |
147,165
| – | – |
|
|
58
Masimo
MASI
$7.41B
| $782K | 0.06% |
5,984
-202,986
| -97% | -$26.5M |
|
|
HSKA
59
DELISTED
Heska Corp
HSKA
| $735K | 0.05% |
7,772
+1,936
| +33% | +$183K |
|
|
SWAV
60
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $631K | 0.04% |
+3,300
| New | +$631K |
|
61
AC Immune
ACIU
$223M
| $450K | 0.03% |
124,589
| – | – |
|
62
Sonida Senior Living
SNDA
$481M
| $319K | 0.02% |
15,209
| – | – |
|
63
Eledon Pharmaceuticals
ELDN
$154M
| $144K | 0.01% |
59,065
-54,943
| -48% | -$134K |
|
64
Bolt Biotherapeutics
BOLT
$9.46M
| $63.6K | ﹤0.01% |
+31,172
| New | +$63.6K |
|
|
CBIO
65
Crescent Biopharma, Inc. Common Stock
CBIO
$186M
| $60.1K | ﹤0.01% |
100,579
| – | – |
|
66
Assembly Biosciences
ASMB
$184M
| – | – |
-280,000
| Closed | -$577K |
|
|
67
Ascendis Pharma
ASND
$12.3B
| – | – |
-417,172
| Closed | -$49M |
|
|
AUTL
68
Autolus Therapeutics
AUTL
$399M
| – | – |
-371,540
| Closed | -$1.55M |
|
69
Cyclerion Therapeutics
CYCN
$7.62M
| – | – |
-371,955
| Closed | -$413K |
|
70
The Ensign Group
ENSG
$9.95B
| – | – |
-10,397
| Closed | -$936K |
|
71
iShares MSCI Taiwan ETF
EWT
$6.12B
| – | – |
0
| – | – |
|
72
Exelixis
EXEL
$9.98B
| – | – |
-203,156
| Closed | -$4.61M |
|
|
73
HCA Healthcare
HCA
$95.2B
| – | – |
-111,440
| Closed | -$27.9M |
|
74
iRhythm Technologies
IRTC
$5.63B
| – | – |
-27,047
| Closed | -$4.26M |
|
75
iShares Russell 2000 ETF
IWM
$66.7B
| – | – |
0
| – | – |
|